Interleukin-1β system in anorectic catabolic tumor-bearing rats

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 7, Issue 4, 2004, Pages 419-426

  Turrin, Nicolas P ^a,b   Ilyin, Sergey E ^c   Gayle, Dave A ^d   Plata Salamán, Carlos R ^c   Ramos, Eduardo J B ^e   Laviano, Alessandro ^e   Das, Undurti N ^e   Inui, Akio ^e   Meguid, Michael M ^e  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITY OF DELAWARE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Anorexia; Cachexia; Feeding; Hippocampus; Hypothalamus; Neuroimmunology

Indexed keywords

3 METHYLCHOLANTHRENE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; LYMPHOTOXIN; MESSENGER RNA; INTERLEUKIN 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOREXIA; BRAIN LEVEL; CANCER; CONTROLLED STUDY; IN VIVO STUDY; LIVER LEVEL; MALE; NEUROLOGIC DISEASE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVIEW; TISSUE DISTRIBUTION; UPREGULATION; ANIMAL; ARTICLE; BIOSYNTHESIS; BRAIN; CACHEXIA; FISCHER 344 RAT; LIVER; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANOREXIA; BRAIN; CACHEXIA; CYTOKINES; INTERFERON TYPE II; INTERLEUKIN-1; LIVER; MALE; NEOPLASMS; RATS; RATS, INBRED F344; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 6944226294     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mco.0000134373.16557.92     Document Type: Review

References (42)

1. Laviano A, Meguid MM, Rossi-Fanelli F. Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies. Lancet Oncol 2003; 4:686-694. An informative, comprehensive and updated review of the scientific and clinical implications of cancer anorexia.
2. Ciesielski KT, Harris RJ, Hart BL, Pabst HF. Cerebellar hypoplasia and frontal lobe cognitive deficits in disorders of early childhood. Neuropsychologia 1997; 35:643-655.
3. Dropcho EJ. Remote neurologic manifestations of cancer. Neurol Clin 2002; 20:85-122, vi.
4. Meyers CA. Neurocognitive dysfunction in cancer patients. Oncology (Huntingt) 2000; 14:75-79; discussion 79, 81-82, 85.
5. Younger DS. Motor neuron disease and malignancy. Muscle Nerve 2000; 23:658-660.
6. Makarenko IG, Meguid MM, Gatto L, et al. Decreased NPY innervation of the hypothalamic nuclei in rats with cancer anorexia. Brain Res 2003; 961:100-108. Using the immunostaining technique, this elegant study demonstrates that, during tumor growth, the development of anorexia is associated with a significant reduction of neuropeptide Y innervation in the hypothalamus, particularly within the supraoptic nucleus, the parvocellular portion of the paraventricular nucleus, and to a lesser extent, the suprachiasmatic and arcuate nuclei.
7. Makarenko IG, Meguid MM, Ugrumov MV. Distribution of serotonin 5-hydroxytriptamine 1B (5-HT(1B)) receptors in the normal rat hypothalamus. Neurosci Lett 2002; 328:155-159.
8. Cravo ML, Gloria LM, Claro I. Metabolic responses to tumour disease and progression: tumour-host interaction. Clin Nutr 2000; 19:459-465.
9. Noguchi Y, Yoshikawa T, Matsumoto A, et al. Are cytokines possible mediators of cancer cachexia? Surg Today 1996; 26:467-475.
10. Plata-Salaman CR. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 2000; 16:1009-1012.
11. Plata-Salaman CR, Ilyin SE, Gayle D. Brain cytokine mRNAs in anorectic rats bearing prostate adenocarcinoma tumor cells. Am J Physiol 1998; 275:R566-R573.
12. Strassmann G, Masui Y, Chizzonite R, Fong M. Mechanisms of experimental cancer cachexia. Local involvement of IL-1 in colon-26 tumor. J Immunol 1993; 150:2341-2345.
13. Debonis D, Meguid MM, Laviano A, et al. Temporal changes in meal number and meal size relationship in response to rHu IL-1 alpha. Neuroreport 1995; 6:1752-1756.
14. Opara EI, Laviano A, Meguid MM, Yang ZJ. Correlation between food intake and CSF IL-1 alpha in anorectic tumor bearing rats. Neuroreport 1995; 6:750-752.
15. Laviano A, Gleason JR, Meguid MM, et al. Effects of intra-VMN mianserin and IL-1ra on meal number in anorectic tumor-bearing rats. J Invest Med 2000; 48:40-48.
16. Laviano A, Renvyle T, Meguid MM, et al. Relationship between interleukin-1 and cancer anorexia. Nutrition 1995; 11 (5 Suppl.):680-683.
17. Laviano A, Rossi Fanelli F, Meguid MM. The brain's normal function. Science 1998; 280:503.
18. Muscaritoli M, Meguid MM, Beverly JL, et al. Mechanism of early tumor anorexia. J Surg Res 1996; 60:389-397.
19. Turrin NP, Gayle D, Ilyin SE, et al. Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide. Brain Res Bull 2001; 54:443-453.
20. Madden RE, Burke D. Production of viable single cell suspension from solid tumors. J Natl Cancer Inst 1961; 27:841-861.
21. Sato T, Meguid MM, Fetissov SO, et al. Hypothalamic dopaminergic receptor expressions in anorexia of tumor-bearing rats. Am J Physiol Regul Integr Comp Physiol 2001; 281:R1907-R1916.
22. Plata-Salaman CR, Ilyin SE, Gayle D, Flynn MC. Gram-negative and Gram-positive bacterial products induce differential cytokine profiles in the brain: analysis using an integrative molecular-behavioral in vivo model. Int J Mol Med 1998; 1:387-397.
23. Ilyin SE, Plata-Salaman CR. In vivo regulation of the IL-1 beta system (ligand, receptors I and II, receptor accessory protein, and receptor antagonist) and TNF-alpha mRNAs in specific brain regions. Biochem Biophys Res Commun 1996; 227:861-867.
24. Ilyin SE, Plata-Salaman CR. HIV-1 gp120 modulates hypothalamic cytokine mRNAs in vivo: implications to cytokine feedback systems. Biochem Biophys Res Commun 1997; 231:514-518.
25. Plata-Salaman CR, Ilyin SE. Interleukin-1 beta (IL-1beta)-induced modulation of the hypothalamic IL-1beta system, tumor necrosis factor-alpha, and transforming growth factor-betal mRNAs in obese (fa/fa) and lean (Fa/Fa) Zucker rats: implications to IL-1beta feedback systems and cytokine-cytokine interactions. J Neurosci Res 1997; 49:541-550.
26. Csiszar A, Szentes T, Haraszti B, et al. Characterisation of cytokine mRNA expression in tumour-infiltrating mononuclear cells and tumour cells freshly isolated from human colorectal carcinomas. Eur Cytokine Network 2001; 12:87-96.
27. Erroi A, Sironi M, Chiaffarino F, et al. IL-1 and IL-6 release by tumor-associated macrophages from human ovarian carcinoma. Int J Cancer 1989; 44:795-801.
28. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405:458-462.
29. Ozaki K, Yoshida S, Ishibashi N, et al. Effect of tumor weight and tube feeding on TNF-alpha and IL-1 beta mRNA expression in the brain of mice. J Parenter Enter Nutr 2001; 25:317-322.
30. Inui A. Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin 2002; 52:72-91.
31. Kurzrock R. The role of cytokines in cancer-related fatigue. Cancer 2001; 92 (6Suppl.):1684-1688.
32. Vernet-der Garabedian B, Lemaigre-Dubreuil Y, Delhaye-Bouchaud N, Mariani J. Abnormal IL-1 beta cytokine expression in the cerebellum of the ataxic mutant mice staggerer and lurcher. Brain Res Mol Brain Res 1998; 62:224-227.
33. Carson LF, Roy S, Cain K, et al. The central response to ovarian carcinoma simulates the response to sepsis. J Surg Res 1998; 75:97-102.
34. Ilyin SE, Gayle D, Gonzalez-Gomez I, et al. Brain tumor development in rats is associated with changes in central nervous system cytokine and neuropeptide systems. Brain Res Bull 1999; 48:363-373.
35. Negri DR, Mezzanzanica D, Sacco S, et al. Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours. Cytokine 2001; 15:27-38.
36. Inui A, Meguid MM. Cachexia and obesity: two sides of one coin? Curr Opin Clin Nutr Metab Care 2003; 6:395-399.
37. Niijima A. The afferent discharges from sensors for interleukin 1 beta in the hepatoportal system in the anesthetized rat. J Auton Nerv Syst 1996; 61:287-291.
38. Lynch MA. Interleukin-1 beta exerts a myriad of effects in the brain and in particular in the hippocampus: analysis of some of these actions. Vitamin Horm 2002; 64:185-219.
39. Matsumoto Y, Yoshida M, Watanabe S, Yamamoto T. Involvement of cholinergic and glutamatergic functions in working memory impairment induced by interleukin-1beta in rats. Eur J Pharmacol 2001; 430:283-288.
40. Schwartz GJ, Plata-Salaman CR, Langhans W. Subdiaphragmatic vagal deafferentation fails to block feeding-suppressive effects of LPS and IL-1 beta in rats. Am J Physiol 1997; 273:R1193-R1198.
41. Laviano A, Yang ZJ, Meguid MM, et al. Hepatic vagus does not mediate IL-1 alpha induced anorexia. Neuroreport 1995; 6:1394-1396.
42. Torelli GF, Meguid MM, Moldawer LL, et al. Use of recombinant human soluble TNF receptor in anorectic tumor-bearing rats. Am J Physiol 1999; 277:R850-R855.